Trials / Completed
CompletedNCT01221805
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,040 (actual)
- Sponsor
- Diagnostica Stago · Industry
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the ability of STA® Liatest® D-Di combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thrombosis (DVT) in a 3 month follow-up.
Detailed description
The study population will be selected from prospective, consecutive ambulatory outpatients suspected of having venous thromboembolism. These patients will first be evaluated using the Wells score: * patients with low or moderate pretest probability will be considered for D-dimer testing, those with D-dimer positive will be considered for an imaging procedure, * patients with high pretest probability will be considered for an imaging procedure. Patients with "low or moderate" pretest probability and a negative D-Dimer result will be followed for 3 months to evaluate potential development of deep venous thrombosis and/or pulmonary embolism. These patients will be contacted by phone 3 month after their first visit.
Conditions
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2016-03-01
- Completion
- 2016-04-01
- First posted
- 2010-10-15
- Last updated
- 2016-08-05
Locations
18 sites across 5 countries: United States, Canada, France, Italy, Spain
Source: ClinicalTrials.gov record NCT01221805. Inclusion in this directory is not an endorsement.